acifran has been researched along with acipimox in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, AA; Brown, AJ; Dowell, SJ; Eilert, M; Elshourbagy, N; Foord, SM; Fraser, NJ; Green, A; Hassall, DG; Ignar, DM; Marshall, FH; Murdock, PR; Pike, NB; Steplewski, K; Szekeres, PG; Wilson, S; Wise, A | 1 |
Boatman, PD; Chen, R; Connolly, DT; Decaire, M; Duong, T; Gharbaoui, T; Johnson, BR; Jung, JK; Richman, JG; Sage, CR; Semple, G; Uy, J | 1 |
2 other study(ies) available for acifran and acipimox
Article | Year |
---|---|
Molecular identification of high and low affinity receptors for nicotinic acid.
Topics: Amino Acid Sequence; Animals; Cell Membrane; CHO Cells; Cricetinae; Databases as Topic; DNA, Complementary; Dose-Response Relationship, Drug; Female; Furans; Humans; Hyperlipidemias; Hypolipidemic Agents; Inhibitory Concentration 50; Male; Molecular Sequence Data; Niacin; Oocytes; Protein Binding; Pyrazines; Rats; Receptors, Nicotinic; RNA, Messenger; Sequence Homology, Amino Acid; Tissue Distribution; Xenopus | 2003 |
Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109b.
Topics: Cell Line; Cyclic AMP; Furans; Humans; Niacin; Receptors, G-Protein-Coupled; Receptors, Nicotinic; Stereoisomerism; Structure-Activity Relationship | 2007 |